Effects of HIV-1 Tat protein on ion secretion and on cell proliferation in human intestinal epithelial cells.

BACKGROUND & AIMS Severe diarrhea and enteropathy of unknown origin are frequent in patients infected with human immunodeficiency type 1 virus (HIV-1). The HIV-1 transactivating factor protein (Tat) is a key factor in the pathogenesis of acquired immunodeficiency syndrome. We investigated whether Tat could directly induce ion secretion and cell damage in enterocytes. METHODS Electrical parameters (ion transport studies) were measured in Caco-2 cell monolayers and in human colonic mucosa specimens mounted in Ussing chambers. The effect of Tat on intestinal mucosa integrity was determined by monitoring the transepithelial electrical resistance of Caco-2 cell monolayers. (3)H-thymidine incorporation and cell count were used to evaluate the effect of Tat on cell growth. Intracellular calcium concentrations were measured at the single-cell level using microfluorometry technique. RESULTS Tat protein induced ion secretion in Caco-2 cells and in human colonic mucosa similar to that induced by bacterial enterotoxins. It also significantly prevented enterocyte proliferation. In both instances, the effect of Tat was maximum at concentrations within the range detected in the sera of HIV-1-infected patients. Anti-Tat antibodies inhibited both effects. Ion secretion and the antiproliferative effects were mediated by L-type Ca(2+) channels. An increase in intracellular calcium concentration in Caco-2 cells was found after addition of Tat. CONCLUSIONS These results indicate that Tat may be involved in HIV-1-related intestinal disease through direct interaction with enterocytes.

[1]  M. Estes,et al.  Microbes and microbial toxins: paradigms for microbial-mucosal interactions. VIII. Pathological consequences of rotavirus infection and its enterotoxin. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[2]  B. Deplancke,et al.  Microbial modulation of innate defense: goblet cells and the intestinal mucus layer. , 2001, The American journal of clinical nutrition.

[3]  A. Ouellette,et al.  Paneth cell defensins and innate immunity of the small bowel. , 2001, Inflammatory bowel diseases.

[4]  E. Janoff,et al.  Emerging concepts in gastrointestinal aspects of HIV-1 pathogenesis and management , 2001, Gastroenterology.

[5]  R. Jaussi,et al.  Signalling properties of an HIV-encoded angiogenic peptide mimicking vascular endothelial growth factor activity. , 2001, The Biochemical journal.

[6]  M. Cataldi,et al.  Pharmacological blockade of ERG K(+) channels and Ca(2+) influx through store-operated channels exerts opposite effects on intracellular Ca(2+) oscillations in pituitary GH(3) cells. , 2000, Molecular pharmacology.

[7]  B. Bizzini,et al.  Procedures for preparing biologically inactive, but immunogenic HIV-1 Tat protein (Tat toxoid) for human use. , 2000, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[8]  A. Nath,et al.  Involvement of Inositol 1,4,5‐Trisphosphate‐Regulated Stores of Intracellular Calcium in Calcium Dysregulation and Neuron Cell Death Caused by HIV‐1 Protein Tat , 1999, Journal of neurochemistry.

[9]  R. Gallo Tat as one key to HIV-induced immune pathogenesis and Pat toxoid as an important component of a vaccine , 1999 .

[10]  W. Walker,et al.  Vascular Endothelial Growth Factor (VEGF) Is Present in Human Breast Milk and Its Receptor Is Present on Intestinal Epithelial Cells , 1999, Pediatric Research.

[11]  D. Kotler Characterization of intestinal disease associated with human immunodeficiency virus infection and response to antiretroviral therapy. , 1999, The Journal of infectious diseases.

[12]  A. Guarino,et al.  Growth hormone stimulates, through tyrosine kinase, ion transport and proliferation in human intestinal cells. , 1999, Journal of pediatric gastroenterology and nutrition.

[13]  R. Sitia,et al.  HIV-I Tat: a polypeptide for all seasons. , 1998, Immunology today.

[14]  R. Rappuoli,et al.  Enterotoxic effect of the vacuolating toxin produced by Helicobacter pylori in Caco-2 cells. , 1998, The Journal of infectious diseases.

[15]  A. Poggi,et al.  HIV-1 Tat inhibits human natural killer cell function by blocking L-type calcium channels. , 1998, Journal of immunology.

[16]  A. Fasano Cellular microbiology: how enteric pathogens socialize with their intestinal host. , 1998, Journal of pediatric gastroenterology and nutrition.

[17]  A. Poggi,et al.  Involvement of Dihydropyridine-sensitive Calcium Channels in Human Dendritic Cell Function , 1998, The Journal of Biological Chemistry.

[18]  P. Reiss,et al.  Improvement of chronic diarrhoea in patients with advanced HIV‐1 infection during potent antiretroviral therapy , 1998, AIDS.

[19]  S. Lu,et al.  Pathophysiology of HIV-associated diarrhea. , 1997, Gastroenterology clinics of North America.

[20]  J. Ziogas,et al.  Effects of N‐ and L‐type calcium channel antagonists and (±)‐Bay K8644 on nerve‐induced catecholamine secretion from bovine perfused adrenal glands , 1997, British journal of pharmacology.

[21]  M. Estes,et al.  The rotavirus enterotoxin NSP4 mobilizes intracellular calcium in human intestinal cells by stimulating phospholipase C-mediated inositol 1,4,5-trisphosphate production. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Eugenia Bruzzese,et al.  Human Serum Immunoglobulin Counteracts Rotaviral Infection in Caco-2 Cells1 , 1996, Pediatric Research.

[23]  R. Soldi,et al.  The angiogenesis induced by HIV–1 Tat protein is mediated by the Flk–1/KDR receptor on vascular endothelial cells , 1996, Nature Medicine.

[24]  B. Gazzard,et al.  Gastrointestinal manifestations of HIV infection , 1996, The Lancet.

[25]  L. Terracciano,et al.  Enterotoxic effect of stool supernatant of Cryptosporidium-infected calves on human jejunum , 1994, Gastroenterology.

[26]  R. Tsien,et al.  A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.

[27]  D. Kotler,et al.  Enteropathy associated with the acquired immunodeficiency syndrome. , 1984, Annals of internal medicine.

[28]  I. Mccoll,et al.  Ion transport in rabbit ileal mucosa. I. Na and Cl fluxes and short-circuit current. , 1971, The American journal of physiology.

[29]  B. Ensoli,et al.  Control of viral replication and disease onset in cynomolgus monkeys by HIV-1 TAT vaccine. , 2000, Journal of biological regulators and homeostatic agents.